Document is current
Any future updates will be listed below
-
Authors
Lyons, T.
Spriggs, M.
Kerkelä, L.
Rosas, F. E. https://orcid.org/0000-0001-7790-6183
Roseman, L. https://orcid.org/0000-0001-9990-6029
Mediano, P. A. M. https://orcid.org/0000-0003-1789-5894
Timmermann, C. https://orcid.org/0000-0002-2281-377X
Oestreich, L.
Pagni, B. A. https://orcid.org/0000-0002-9496-7604
Zeifman, R. J.
Hampshire, A.
Trender, W. https://orcid.org/0000-0003-3947-5532
Douglass, H. M. https://orcid.org/0000-0002-4033-385X
Girn, M. https://orcid.org/0000-0003-0455-4273
Godfrey, K.
Kettner, H.
Sharif, F. https://orcid.org/0000-0001-6656-4616
Espasiano, L.
Gazzaley, A. https://orcid.org/0000-0002-1232-9431
Wall, M. B. https://orcid.org/0000-0002-0493-6274
Erritzoe, D. https://orcid.org/0000-0002-7022-6211
Nutt, D. J. https://orcid.org/0000-0002-1286-1401
Carhart-Harris, R. L. https://orcid.org/0000-0002-6062-7150
- License Information
-
More Information
Article History
Received: 4 March 2025
Accepted: 1 April 2026
First Online: 5 May 2026
Competing interests
: The authors declare the following competing interests: R.C.-H. is a scientific advisor to Atai Beckley, Otsuka, and Entropy Neurodynamics. D.J.N. is a scientific advisor to COMPASS Pathways, Neural Therapeutics, Algernon Pharmaceuticals and Alvarius. R.J.Z. has received financial compensation for serving as a consultant to Beckley Clinical. R.C.-H., D.J.N., and R.J.Z. declare no additional competing interests. L.T., M.S., L.K., F.E.R., L.R., P.A.M.M., C.T., L.O., B.A.P., A.H., W.T., H.M.D., M.G., K.G., H.K., F.S., L.E., A.G., M.B.W., and D.E. declare no competing interests.
